Best practice of the most popular drug packaging i

Best practice of drug packaging inkjet innovation

release date: Source: Internet editor: lychee browsing times: 1390 copyright and disclaimer

core tip: developed economies once dominated the drug market for a long time, and now emerging countries/regions are gradually catching up. The rapid growth of drug demand in Africa, Asia and Latin America (called "emerging drug economy" by IMS Health) is a fact that the packaging industry must deal with. Creating packaging that resonates with local markets is critical to success in emerging markets. This will promote packaging innovation, and then promote the innovation of inkjet and labeling technology, and provide pharmaceutical manufacturers with more choices than ever before. However, a successful global drug expansion strategy should be based on best practices to ensure that patients around the world can safely use drugs

[China Packaging News] developed economies once dominated the pharmaceutical market for a long time, and now emerging countries/regions are gradually catching up. The rapid growth of drug demand in Africa, Asia and Latin America (called "emerging drug economy" by IMS Health) is a fact that the packaging industry must deal with. Creating packaging that resonates with local markets is critical to success in emerging markets. This will promote packaging innovation, and then promote the innovation of inkjet and labeling technology, and provide pharmaceutical manufacturers with more choices than ever before. However, a successful global drug expansion strategy should be based on best practices to ensure that patients around the world can safely use drugs

with the increase of wealth in emerging markets, the expenditure on health care has also increased significantly. The investment of the government, non-governmental organizations (NGOs) and the private sector in the health care system is driving the growth of the drug market. The growing economic strength and the growing middle class together constitute the main driving force for the expansion of the drug market. By 2016, drug expenditure in the Asia Pacific region is expected to grow at a compound annual growth rate (CAGR) of about 12.5%, followed by Africa at 10.6%, and Latin America at 10.5% in the same period. At the same time, between 2014 and 2017, the demand for vanadium will multiply, and the drug expenditure in mature markets such as North America, Europe and Japan will increase by a more modest single digit percentage (source: IMS Health). Global attention to the expansion of drugs in emerging markets is driving the urgent need for global serialization and traceability, with the goal of protecting supply chain integrity and patient safety

code printing is the foundation

by 2017, the total global drug expenditure is expected to exceed US $1trillion (source: Hermes Market Research Company), and meeting the needs of standardized serialized drug packaging has become a key issue. At present, most developed economies are strengthening legislation to prevent counterfeit drug packaging and protect patient safety. For the pharmaceutical industry, thousands of packaging lines need to be replaced, with a capital of $7billion. However, without the use of accurate inkjet and identification technology, the serialization work will not be carried out effectively, and in the worst case, it may lead to costly product recalls and fines. Therefore, Drug packaging manufacturers investing in the "emerging drug" market must be aware of the challenges they face and ensure business safety by implementing the latest inkjet and labeling technologies.

emerging drug packaging growth

correct product inkjet for drug packaging manufacturers interested in taking a place in emerging markets (regardless of size) Is crucial. Using the latest technology provided by the market, manufacturers can expand their product portfolio in terms of the range of materials used and production efficiency, and adopt more innovative packaging solutions. For example, due to its advantages in product protection, patient compliance and daily and weekly dose support, blister packaging has become the fastest-growing packaging type in emerging drug markets

now the inkjet technology is mainly used for secondary packaging (such as cartons), but the market is gradually showing interest in inkjet printing on primary packaging (such as blister packaging). Because of this, now there are a series of printing solutions available in these two 1959 -pope Ding A. (POP) pointed out that the fatigue life obeys the logarithmic normal distribution, and the printing code is sprayed on the packaging type. However, when choosing the appropriate technology, manufacturers first need to consider the material characteristics and the available printing area. Material properties, as well as uptime and coding resolution requirements, will affect the determination of the optimal printing solution for the specified serialization plan

after successfully printing the code that can be used for tracking and tracing

ensuring that the corresponding printing function is available, the next step is to capture product information (such as equipment and product identifiers) so that it can be tracked throughout the supply chain. Stable product control is essential to avoid nonconforming products. Two different methods are considered best practices: direct integration of the inkjet and inspection system into the cartoning machine or a dedicated transfer system

strategies are needed to manage the large amount of product information created in the whole supply chain. This can be achieved through aggregation, that is, the unique code created on the outer package is directly connected to the small package inside the package. Products sprayed in the way of aggregation do not need to be unpacked for scanning in the process of passing through the whole supply chain. In the downstream of the supply chain, reading the container or pallet code can infer that all the internal small packages connected to the outer container are inside. Obviously, in this way, the quality of inkjet code and data integrity are crucial. In order to gather the cartons or bottles into the container, the serial number should be stenciled at the last moment, preferably immediately after the products are put into the container, so as to ensure the integrity of the data

finally, manufacturers should use authoritative data sources such as manufacturing execution system (MES), supervisory control and data acquisition system (SCADA), enterprise resource planning (ERP) or similar sources. In this way, the company can ensure that the appropriate information is automatically invoked for the inkjet printer when the operator selects a job. According to UPS' 2013 report "pain in the supply chain", 56% of healthcare companies found that it investment (including bar code inkjet and electronic pedigree Technology) could help them successfully deal with product security issues

flexibility is the key

due to the continuous evolution of tracking and traceability serialization regulations worldwide, including Latin America, North America, Southeast Asia and Europe, careful consideration of local market requirements is the key to success. Pharmaceutical packaging manufacturers must invest in printing solutions that address current and future regulatory requirements and local specific needs. In view of the rapid growth of the market and the uncertain regulatory requirements in the future, flexible printing solutions should be selected, and the life of manufacturers will be easier. Ideally, your technology provider should provide an operator-friendly standard interface that is compatible with a variety of inkjet printing technologies, which can simplify the user experience no matter what technology is used.% Because of data input errors, centralized information management can eliminate the requirement of creating data on the production line and help to ensure that the correct code is sprayed on the target product. Therefore, in the increasingly complex global drug market, the correct inkjet printer is a driving factor to improve productivity

Richard nemesis is the global vertical manager of drugs and medical devices at Videojet technologies. His main responsibilities in the company are to have an in-depth understanding of the global development trend and customer needs of the inkjet industry, formulate marketing plans to support sales, and provide suggestions on equipment functions for the product development team. He previously worked as a system sales specialist in the IBM System and technology group

videojet technologies is a leader in the global product identification market, providing inkjet printing, printing and identification products, inks/solvents for specific applications, and product life cycle services. Our goal is to cooperate with customers in the packaging consumer goods, pharmaceutical and industrial products industries, help customers improve productivity, protect and promote customer brand development, and become a leader in industry trends and standards. Weidijie has customer application experts and leading technologies such as small character inkjet (CIJ), thermal foaming inkjet (TIJ), laser logo, thermal transfer printing (TTO), container inkjet and labeling, and a wide range of wide array inkjet printing. So far, the installed capacity of vidigit in the world has exceeded 325000. Every day, more than 10 billion products are sprayed by our customers with Viagra products. With more than 3000 team members in 26 countries/regions around the world, we provide customers with direct sales, application, service and training support. In addition, another prospective utilization is the cooling and target heating of Peltier components in the slotted sleeve section, and the distribution network of VDJ includes more than 400 distributors and OEMs, covering 135 countries/regions